论文部分内容阅读
[目的]分析急性高血糖对ST段抬高急性心肌梗死患者预后的影响。[方法]STEMI患者175例,分为A组:既往糖尿病史+急性高血糖组,B组:急性高血糖组,C组:无急性高血糖组;对3组患者入院时的各项指标和院内不良事件发生情况进行比较。[结果]C组患者血糖值和心肌酶明显低于A、B两组,差异有统计学意义(P﹤0.05);C组患者的Killip分级构成比与A、B两组明显不同,差异有统计学意义(P﹤0.05);B组患者心肌酶明显低于A组,差异有统计学意义(P﹤0.05);C组无院内不良事件的比例明显高于A、B两组,差异有统计学意义(P﹤0.05);C组的患者病死率明显低于A、B组,差异有统计学意义(P﹤0.05);随机血糖、心肌酶、Killip分级与院内不良事件发生率呈正相关。[结论]STEMI急性高血糖患者院内发生不良事件及死亡的危险性显著高于入院时血糖正常者。
[Objective] To analyze the effect of acute hyperglycemia on the prognosis of patients with ST-elevation acute myocardial infarction. [Methods] 175 patients with STEMI were divided into group A: history of previous diabetes + acute hyperglycemia group, group B: acute hyperglycemia group, group C: no acute hyperglycemia group; Hospital adverse events were compared. [Results] The blood glucose and myocardial enzymes in group C were significantly lower than those in groups A and B (P <0.05). The scores of Killip classification in group C were significantly different from those in groups A and B (P <0.05). The level of myocardial enzymes in group B was significantly lower than that in group A (P <0.05). The proportion of non-hospital-related adverse events in group C was significantly higher than that in group A and B (P <0.05). The mortality of patients in group C was significantly lower than that of group A and B (P <0.05). There was a positive correlation between random glucose, myocardial enzymes and Killip grade and the incidence of nosocomial adverse events . [Conclusion] The incidence of adverse events and the risk of death in STEMI patients with acute hyperglycemia were significantly higher than those with normal blood glucose at admission.